Lindsey T. Brinton

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index879citations56works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Histone Deacetylase Inhibitors Research(18), Protein Degradation and Inhibitors(18), Acute Myeloid Leukemia Research(8), Peptidase Inhibition and Analysis(8), HIV/AIDS drug development and treatment(6)

Publications56 total

Comparison of Gene Expression Alterations Induced by Glucocorticoids, Thiazolidinediones, and Mifepristone Associated with Proteinuria Reduction in Puromycin Aminonucleoside-Induced Nephrotic Syndrome (PAN-NS)
Journal of the American Society of Nephrology·2025
A phase 1/2, first-in-human trial of ZB131, a novel antibody targeting cancer-specific plectin (CSP) in advanced solid tumors.
Journal of Clinical Oncology·2023· 2 cited
Abstract 6299: ZB131 antibody-drug conjugates induce potent antitumor activity
Cancer Research·2023
Supplementary Figures & Tables from BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
2023Open Access
Data from BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
2023Open Access
Data from BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
2023Open Access
Supplementary Methods from BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
2023Open Access
Supplementary Methods from BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
2023Open Access
Supplementary Figures & Tables from BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
2023Open Access
Supplementary Figure S5 from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
Supplementary Methods from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
Supplementary Figure S4 from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
Supplementary Figure S6 from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
Supplementary Figure S1 from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
Supplementary Figure S1 from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
Supplementary Figure S2 from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
Supplementary Methods from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
Data from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
Supplementary Figure S4 from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
Supplementary Figure S3 from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Rosa Lapalombella(35), James S. Blachly(33), Katie Williams(32), John C. Byrd(30), Larry Beaver(29), Lapo Alinari(26), Deepa Sampath(25), Amy M. Lehman(24), Shaneice Mitchell(22), Nicole R. Grieselhuber(22), Daniel Canfield(22), Steven Sher(22), Tzung-Huei Lai(22), Shelley Orwick(21), Hannah Phillips(21), Pearlly S. Yan(20), Matthew V. Cannon(20), Pu Zhang(18), Alice S. Mims(16), Christopher C. Coss(16)